{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T14:58:12Z","timestamp":1778770692093,"version":"3.51.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T00:00:00Z","timestamp":1595203200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T00:00:00Z","timestamp":1595203200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Young Scientists of China","award":["No. 81602597"],"award-info":[{"award-number":["No. 81602597"]}]},{"name":"Research Project of Shaanxi Province","award":["No. 2018JM7017"],"award-info":[{"award-number":["No. 2018JM7017"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s00432-020-03325-4","type":"journal-article","created":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T05:28:47Z","timestamp":1595222927000},"page":"223-233","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Stem signatures associated antibodies yield early diagnosis and precise prognosis predication of patients with non-small cell lung cancer"],"prefix":"10.1007","volume":"147","author":[{"given":"Si-Si","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zi-Yang","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Dong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-Chang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chong-Wen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cai-lin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bao-Cheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shou-Ching","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5909-5786","authenticated-orcid":false,"given":"Xin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,20]]},"reference":[{"issue":"9","key":"3325_CR1","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1001\/jama.297.9.953","volume":"297","author":"PB Bach","year":"2007","unstructured":"Bach PB et al (2007) Computed tomography screening and lung cancer outcomes. JAMA 297(9):953\u2013961","journal-title":"JAMA"},{"issue":"22","key":"3325_CR2","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1001\/jama.2012.5521","volume":"307","author":"PB Bach","year":"2012","unstructured":"Bach PB et al (2012) Benefits and harms of CT screening for lung cancer: a systematic review. JAMA 307(22):2418\u20132429","journal-title":"JAMA"},{"key":"3325_CR3","doi-asserted-by":"crossref","unstructured":"Blandin Knight S et al (2017) Progress and prospects of early detection in lung cancer. Open Biol 7(9)","DOI":"10.1098\/rsob.170070"},{"issue":"2","key":"3325_CR4","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1093\/annonc\/mdq361","volume":"22","author":"P Boyle","year":"2011","unstructured":"Boyle P et al (2011) Clinical validation of an autoantibody test for lung cancer. Ann Oncol 22(2):383\u2013389","journal-title":"Ann Oncol"},{"issue":"3","key":"3325_CR5","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1136\/thx.2007.083592","volume":"63","author":"CJ Chapman","year":"2008","unstructured":"Chapman CJ et al (2008) Autoantibodies in lung cancer: possibilities for early detection and subsequent cure. Thorax 63(3):228\u2013233","journal-title":"Thorax"},{"issue":"5","key":"3325_CR6","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1007\/s13277-012-0379-2","volume":"33","author":"CJ Chapman","year":"2012","unstructured":"Chapman CJ et al (2012) EarlyCDT(R)-Lung test: improved clinical utility through additional autoantibody assays. Tumour Biol 33(5):1319\u20131326","journal-title":"Tumour Biol"},{"issue":"8","key":"3325_CR7","doi-asserted-by":"publisher","first-page":"505","DOI":"10.7326\/0003-4819-152-8-201004200-00007","volume":"152","author":"JM Croswell","year":"2010","unstructured":"Croswell JM et al (2010) (2010) Cumulative incidence of false-positive test results in lung cancer screening: a randomized trial. Ann Intern Med 152(8):505\u2013512 (W176-80)","journal-title":"Ann Intern Med"},{"issue":"1","key":"3325_CR8","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1177\/1430.15817","volume":"100","author":"JJ Grah","year":"2014","unstructured":"Grah JJ et al (2014) Clinical significance of immunohistochemical expression of cancer\/testis tumor-associated antigens (MAGE-A1, MAGE-A3\/4, NY-ESO-1) in patients with non-small cell lung cancer. Tumori 100(1):60\u201368","journal-title":"Tumori"},{"issue":"12","key":"3325_CR9","doi-asserted-by":"publisher","first-page":"e82241","DOI":"10.1371\/journal.pone.0082241","volume":"8","author":"B Gyorffy","year":"2013","unstructured":"Gyorffy B et al (2013) Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer. PLoS ONE 8(12):e82241","journal-title":"PLoS ONE"},{"key":"3325_CR10","doi-asserted-by":"publisher","first-page":"116630","DOI":"10.1016\/j.lfs.2019.116630","volume":"232","author":"G Huang","year":"2019","unstructured":"Huang G et al (2019) TUSC7 suppression of Notch activation through sponging MiR-146 recapitulated the asymmetric cell division in lung adenocarcinoma stem cells. Life Sci 232:116630","journal-title":"Life Sci"},{"issue":"1","key":"3325_CR11","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1158\/0008-5472.CAN-18-2032","volume":"79","author":"AV Kossenkov","year":"2019","unstructured":"Kossenkov AV et al (2019) A gene expression classifier from whole blood distinguishes benign from malignant lung nodules detected by low-dose CT. Cancer Res 79(1):263\u2013273","journal-title":"Cancer Res"},{"issue":"11","key":"3325_CR12","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1093\/clinchem\/48.11.1931","volume":"48","author":"J Kulpa","year":"2002","unstructured":"Kulpa J et al (2002) Carcinoembryonic antigen, squamous cell carcinoma antigen, CYFRA 21\u20131, and neuron-specific enolase in squamous cell lung cancer patients. Clin Chem 48(11):1931\u20131937","journal-title":"Clin Chem"},{"issue":"7","key":"3325_CR13","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1158\/1940-6207.CAPR-10-0328","volume":"4","author":"S Lam","year":"2011","unstructured":"Lam S et al (2011) EarlyCDT-Lung: an immunobiomarker test as an aid to early detection of lung cancer. Cancer Prev Res (Phila) 4(7):1126\u20131134","journal-title":"Cancer Prev Res (Phila)"},{"issue":"10","key":"3325_CR14","doi-asserted-by":"crossref","first-page":"101042831771166","DOI":"10.1177\/1010428317711662","volume":"39","author":"P Li","year":"2017","unstructured":"Li P et al (2017) Evaluation of serum autoantibodies against tumor-associated antigens as biomarkers in lung cancer. Tumour Biol 39(10):1010428317711662","journal-title":"Tumour Biol"},{"issue":"2","key":"3325_CR15","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1177\/1724600819834235","volume":"34","author":"C Mauro","year":"2019","unstructured":"Mauro C et al (2019) New and old biomarkers in the differential diagnosis of lung cancer: pro-gastrin-releasing peptide in comparison with neuron-specific enolase, carcinoembryonic antigen, and CYFRA 21-1. Int J Biol Mark 34(2):163\u2013167. https:\/\/doi.org\/10.1177\/1724600819834235","journal-title":"Int J Biol Mark"},{"key":"3325_CR16","doi-asserted-by":"publisher","first-page":"117727191775160","DOI":"10.1177\/1177271917751608","volume":"13","author":"PJ Mazzone","year":"2018","unstructured":"Mazzone PJ et al (2018) Evaluation of a serum lung cancer biomarker panel. Biomark Insights 13:1177271917751608","journal-title":"Biomark Insights"},{"issue":"8","key":"3325_CR17","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1093\/annonc\/mdp606","volume":"21","author":"A Murray","year":"2010","unstructured":"Murray A et al (2010) Technical validation of an autoantibody test for lung cancer. Ann Oncol 21(8):1687\u20131693","journal-title":"Ann Oncol"},{"issue":"9","key":"3325_CR18","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s00595-017-1477-y","volume":"47","author":"H Nakamura","year":"2017","unstructured":"Nakamura H, Nishimura T (2017) History, molecular features, and clinical importance of conventional serum biomarkers in lung cancer. Surg Today 47(9):1037\u20131059","journal-title":"Surg Today"},{"issue":"5","key":"3325_CR19","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1056\/NEJMoa1102873","volume":"365","author":"National Lung Screening Trial Research T","year":"2011","unstructured":"National Lung Screening Trial Research T et al (2011) Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365(5):395\u2013409","journal-title":"N Engl J Med"},{"issue":"12","key":"3325_CR20","doi-asserted-by":"publisher","first-page":"e754","DOI":"10.1016\/S1470-2045(17)30861-6","volume":"18","author":"M Oudkerk","year":"2017","unstructured":"Oudkerk M et al (2017) European position statement on lung cancer screening. Lancet Oncol 18(12):e754\u2013e766","journal-title":"Lancet Oncol"},{"issue":"1","key":"3325_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1476-5586(04)80047-2","volume":"6","author":"DR Rhodes","year":"2004","unstructured":"Rhodes DR et al (2004) ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia 6(1):1\u20136","journal-title":"Neoplasia"},{"issue":"2","key":"3325_CR22","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1593\/neo.07112","volume":"9","author":"DR Rhodes","year":"2007","unstructured":"Rhodes DR et al (2007) Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia 9(2):166\u2013180","journal-title":"Neoplasia"},{"issue":"10","key":"3325_CR23","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1097\/JTO.0b013e31829fd3d5","volume":"8","author":"H Roberts","year":"2013","unstructured":"Roberts H et al (2013) Screening high-risk populations for lung cancer: guideline recommendations. J Thorac Oncol 8(10):1232\u20131237","journal-title":"J Thorac Oncol"},{"issue":"3","key":"3325_CR24","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.jtho.2018.11.023","volume":"14","author":"LM Seijo","year":"2019","unstructured":"Seijo LM et al (2019) Biomarkers in lung cancer screening: achievements, promises, and challenges. J Thorac Oncol 14(3):343\u2013357","journal-title":"J Thorac Oncol"},{"issue":"1","key":"3325_CR25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21387","volume":"67","author":"RL Siegel","year":"2017","unstructured":"Siegel RL, Miller KD, Jemal A (2017) Cancer Statistics, 2017. CA Cancer J Clin 67(1):7\u201330","journal-title":"CA Cancer J Clin"},{"issue":"32","key":"3325_CR26","doi-asserted-by":"publisher","first-page":"32944","DOI":"10.18632\/oncotarget.5079","volume":"6","author":"X Sun","year":"2015","unstructured":"Sun X et al (2015) MiR-208a stimulates the cocktail of SOX2 and beta-catenin to inhibit the let-7 induction of self-renewal repression of breast cancer stem cells and formed miR208a\/let-7 feedback loop via LIN28 and DICER1. Oncotarget 6(32):32944\u201332954","journal-title":"Oncotarget"},{"issue":"W1","key":"3325_CR27","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang Z et al (2017) GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res 45(W1):W98\u2013W102","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"3325_CR28","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/nrc.2016.56","volume":"16","author":"AJ Vargas","year":"2016","unstructured":"Vargas AJ, Harris CC (2016) Biomarker development in the precision medicine era: lung cancer as a case study. Nat Rev Cancer 16(8):525\u2013537","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"3325_CR29","first-page":"17","volume":"35","author":"B Vatankulu","year":"2016","unstructured":"Vatankulu B et al (2016) Accuracy of FDG-PET\/CT and paraneoplastic antibodies in diagnosing cancer in paraneoplastic neurological syndromes. Rev Esp Med Nucl Imagen Mol 35(1):17\u201321","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"issue":"1","key":"3325_CR30","doi-asserted-by":"publisher","first-page":"e12534","DOI":"10.1111\/cpr.12534","volume":"52","author":"M Wang","year":"2019","unstructured":"Wang M et al (2019) H19 regulation of oestrogen induction of symmetric division is achieved by antagonizing Let-7c in breast cancer stem-like cells. Cell Prolif 52(1):e12534","journal-title":"Cell Prolif"},{"key":"3325_CR31","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.omtn.2019.10.039","volume":"19","author":"H Wang","year":"2020","unstructured":"Wang H et al (2020) Long noncoding RNA LINC01116 contributes to gefitinib resistance in non-small cell lung cancer through regulating IFI44. Mol Ther Nucl Acids 19:218\u2013227","journal-title":"Mol Ther Nucl Acids"},{"issue":"21","key":"3325_CR32","doi-asserted-by":"publisher","first-page":"2972","DOI":"10.1080\/15384101.2019.1664225","volume":"18","author":"G Xiao","year":"2019","unstructured":"Xiao G et al (2019) FAM83A-AS1 promotes lung adenocarcinoma cell migration and invasion by targeting miR-150-5p and modifying MMP14. Cell Cycle 18(21):2972\u20132985","journal-title":"Cell Cycle"},{"issue":"3","key":"3325_CR33","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.bbrc.2012.06.050","volume":"423","author":"Y Yao","year":"2012","unstructured":"Yao Y et al (2012) Potential application of non-small cell lung cancer-associated autoantibodies to early cancer diagnosis. Biochem Biophys Res Commun 423(3):613\u2013619","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-020-03325-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-020-03325-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-020-03325-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T23:44:29Z","timestamp":1626738269000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-020-03325-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,20]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["3325"],"URL":"https:\/\/doi.org\/10.1007\/s00432-020-03325-4","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,20]]},"assertion":[{"value":"2 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors report no conflicts of interest in this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}